Thompson Davis & Co., Inc. Zynerba Pharmaceuticals, Inc. Transaction History

Thompson Davis & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.88 - $4.3 $4,417 - $6,596	-1,534 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$5.59 - $10.45 $20,073 - $37,525	-3,591 Reduced 70.07%	1,534 $13,000
Q4 2017 Feb 05, 2018	BUY	$8.69 - $14.59 $44,536 - $74,773	5,125	5,125 $64,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.